The CRO Market Outlook: Emerging markets, leading players and future trends - 2009/08/27 - Business Insights

Report title: The CRO Market Outlook: Emerging markets, leading players and future trends

from Business Insights
167 page report published Aug 27, 2009

Price $3,835.00 available for immediate download

Report Overview

Table of Contents

Search Inside

About Business Insights

IntroductionRising costs and falling productivity, among other trends are driving pharmaceutical companies to outsource an increasing range of functions to CROs in search of time and cost savings. This produced strong double-digit growth in the sector between 2003 and 2008. However, amongst other resistors, the financial crisis resulted in reduced funding available for biotech companies. This fully updated CRO Market Outlook assesses the market drivers and resistors and predicts the effects of these. The report analyzes the overarching trends in the industry; examines which regions are set to see growth in CRO activity; evaluates the leading CROs; and outlines the future of the industry. The report provides insight into conditions into seven emerging regions including China, India and Latin America. It highlights the evolving business and relationship models between CROs and sponsor companies and enables optimal outsourcing strategy.Key features of this report
- Identifies and analyses the most recent trends and issues in outsourcing clinical R&D
- Describes where clinical trials will be conducted in the future
- Explores the complexities and the costs of outsourcing R&D to different world regions
- Profiles the major international CRO players
- Provides a detailed assessment of the current CRO market including market share information and the size/growth of R&D spending
- Focuses on emerging CRO markets
- Highlights evolving strategies for working with CROs
- Examines existing and future CRO business modelsKey findings from this report
- The total CRO market size is estimated at $20bn in 2008 and expected to grow at an annual rate of 8.5% to reach $35bn through 2015. The market is highly fragmented and the number of CROs worldwide has reached over 1,100 despite continued consolidation.
- CROs provide substantial global capacity to drug developers and have become a critical contributor to clinical trial activity. Clinical trials conducted by CROs are completed up to 30% more quickly than those conducted in-house by pharma companies.
- Of the large, global contract research providers, Quintiles is market leader, with 15% of the global market share, followed by Covance and PPD. The five largest CROs have increased their market share and now hold 55% of the total market.
- The leading CROs are commodity full service providers operating on a global scale. They act as one-stop shops for all services, from preclinical through marketing.
- The number of clinical studies conducted in Asia, Central and Eastern Europe and Latin America is constantly rising. India and China are the future outsourcing destinations of choice.
- CROs and pharmaceutical companies are turning to strategic partnerships to gain a competitive edge in the global business environment.

Source:

Business Insights

Document ID:

rbcr0015

Industry:

Food

Industry:

Pharmaceutical

Free Sample:

Click Here to Download

Format:

PDF

Title	Starting Page	Number of Pages
Sections
Table of Contents The CRO Market Outlook to 2014 Executive Summary 12 The global contract research organization market 12 CRO market analysis 13 Established regions in the global CRO market 14 Emerging regions in the global CRO market 14 Leading players in	0	1
Table of Contents	0	1
The CRO Market Outlook to 2014	0	1
Executive Summary 12	0	1
The global contract research organization market 12	0	1
CRO market analysis 13	0	1
Established regions in the global CRO market 14	0	1
Emerging regions in the global CRO market 14	0	1
Leading players in the global CRO market 15	0	1
The future of contract research 16	0	1
Chapter 1 The global contract research organization market 20	0	1
Summary 20	0	1
Introduction 21	0	1
The CRO contribution to drug development 21	0	1
Market overview 23	0	1
Key market drivers 23	0	1
Key market restraints 24	0	1
Conclusions and key findings 25	0	1
Overview of the global CRO market 26	0	1
Total revenue forecasts 26	0	1
Global R&D expenditure and CRO market size 27	0	1
Global clinical development outsourcing 28	0	1
The contribution of CRO to drug development 29	0	1
Current market drivers 31	0	1
Growth of R&D expenditure from biotech and pharma 31	0	1
Cost pressures encourage R&D outsourcing 33	0	1
Long term growth and R&D expenditure of biotechnology companies 36	0	1
Growing regulatory burden and safety concerns 37	0	1
US 37	0	1
EU 38	0	1
Patient recruitment 39	0	1
Increasing number of products in development 39	0	1
The development of biomarkers 40	0	1
Current market restraints 41	0	1
Near term reductions in biotech R&D spending 41	0	1
Growing competition and customer consolidation 42	0	1
New financial realities alter biopharmaceutical outsourcing landscape 43	0	1
Shortage of clinical research personnel 43	0	1
Electronic data capture: a threat to CRO revenue 44	0	1
Key market trends 46	0	1
Globalization 46	0	1
EDC evolution 46	0	1
Strategic alliances 47	0	1
Chapter 2 CRO market analysis 52	0	1
Summary 52	0	1
Introduction 53	0	1
Market conditions 53	0	1
Competitive analysis 54	0	1
Market share analysis 54	0	1
Competitive dynamics 55	0	1
Academic medical centers 56	0	1
Site management organizations 57	0	1
Laboratory analytical services 58	0	1
Non-CRO niche service providers 59	0	1
Conclusion 59	0	1
CRO service models 59	0	1
Introduction 59	0	1
The full service model 60	0	1
SWOT analysis 63	0	1
The niche model 64	0	1
SWOT analysis 65	0	1
Industry strategies 66	0	1
Consolidation: Mergers & acquisitions in the CRO industry 66	0	1
Expanding the continuum of services: vertical integration 67	0	1
Forward integration 67	0	1
Backward integration 68	0	1
Industry challenges 69	0	1
Consolidation within the CRO industry: a threat to close customer relationships 69	0	1
Strategic outsourcing: demonstrating clear value to clients 70	0	1
Co-development: sharing the risk 71	0	1
Chapter 3 Established regions in the global CRO market 74	0	1
Summary 74	0	1
Introduction 75	0	1
The US CRO market 75	0	1
Overview 75	0	1
Drivers of the US CRO market 77	0	1
Challenges of the US CRO market 78	0	1
Competitive dynamics 80	0	1
The CRO market in Western Europe 81	0	1
Overview 81	0	1
Infrastructure and local regulations 82	0	1
Drivers of the CRO market in Western Europe 84	0	1
Challenges of the CRO market in Western Europe 85	0	1
Competitive dynamics 86	0	1
Chapter 4 Emerging regions in the global CRO market 88	0	1
Summary 88	0	1
Introduction 89	0	1
The Central and Eastern European CRO market 91	0	1
Overview 91	0	1
Infrastructure and local regulations 92	0	1
Benefits of outsourcing to CEE 94	0	1
Challenges of outsourcing to CEE 95	0	1
Competitive dynamics 95	0	1
The CRO market in China 97	0	1
Overview 97	0	1
Infrastructure and local regulations 98	0	1
Benefits of outsourcing to China 99	0	1
Challenges of outsourcing to China 100	0	1
Competitive dynamics 101	0	1
The CRO market in India 104	0	1
Overview 104	0	1
Infrastructure and local regulations 104	0	1
Intellectual property 105	0	1
Legislative reforms 105	0	1
Benefits of outsourcing to India 106	0	1
Challenges of outsourcing to India 106	0	1
Competitive dynamics 108	0	1
The CRO market in Latin America 110	0	1
Overview 110	0	1
Infrastructure and local regulations 111	0	1
Argentina 112	0	1
Brazil 112	0	1
Mexico 113	0	1
Benefits of outsourcing to Latin America 113	0	1
Challenges of outsourcing to Latin America 114	0	1
Competitive dynamics 115	0	1
The CRO markets in South Korea and Turkey 116	0	1
Overview 116	0	1
Infrastructure and local regulations 118	0	1
Benefits of outsourcing to South Korea 118	0	1
Challenges of outsourcing to South Korea 118	0	1
Benefits of outsourcing to Turkey 119	0	1
Challenges of outsourcing to Turkey 119	0	1
Competitive dynamics 119	0	1
Chapter 5 Leading players in the global CRO market 122	0	1
Summary 122	0	1
Introduction 123	0	1
The client perspective 124	0	1
Capabilities of leading CROs 125	0	1
Quintiles Transnational Corp 127 Company profile 127 Business description 127 Partnering collaborations and recent deals 128 Covance 129 Company profile 129 Business description 129 Partnering collaborations and recent deals 130 PPD Inc. 131 Company profil	0	1

Enter the keyword(s) which you would like to search for within this document and click "Search"

Business Insights provides a single, off-the-shelf, objective source of data, analysis and market insight. Business Insights work in association with leading industry experts to produce a range of reports across a wide range of industry sectors.

Price: $3,835.00

Free Sample

Questions about
this research?

Send page to a friend

Return to
Alacra Company Snapshot

Can't Decide?

Purchasing premium research sight unseen can be intimidating. At Alacra we want you to know what you are getting. Visit our FAQ or ask our Customer Service Team any questions about the report you are considering purchasing.